180 related articles for article (PubMed ID: 35589016)
1. Upregulation of hepatic CD36 via glucocorticoid receptor activation contributes to dexamethasone-induced liver lipid metabolism disorder in mice.
Chen M; Bai M; Yi Y; Lu S; Luo J; Li P; Zhang H; Jiang H; Zhou H
Toxicol Lett; 2022 Jun; 363():1-10. PubMed ID: 35589016
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of hepatic CD36 by increased corticosterone/cortisol levels via GR leads to lipid accumulation in liver and hypertriglyceridaemia during pregnancy.
Bai M; Chen M; Zeng Q; Lu S; Li P; Ma Z; Lin N; Zheng C; Zhou H; Zeng S; Sun D; Jiang H
Br J Pharmacol; 2022 Sep; 179(17):4440-4456. PubMed ID: 35491243
[TBL] [Abstract][Full Text] [Related]
3. Conditional ablation of mediator subunit MED1 (MED1/PPARBP) gene in mouse liver attenuates glucocorticoid receptor agonist dexamethasone-induced hepatic steatosis.
Jia Y; Viswakarma N; Fu T; Yu S; Rao MS; Borensztajn J; Reddy JK
Gene Expr; 2009; 14(5):291-306. PubMed ID: 19630272
[TBL] [Abstract][Full Text] [Related]
4. Activation of GR but not PXR by dexamethasone attenuated acetaminophen hepatotoxicities via Fgf21 induction.
Vispute SG; Bu P; Le Y; Cheng X
Toxicology; 2017 Mar; 378():95-106. PubMed ID: 28088388
[TBL] [Abstract][Full Text] [Related]
5. Prolactin improves hepatic steatosis via CD36 pathway.
Zhang P; Ge Z; Wang H; Feng W; Sun X; Chu X; Jiang C; Wang Y; Zhu D; Bi Y
J Hepatol; 2018 Jun; 68(6):1247-1255. PubMed ID: 29452209
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia activates the aryl hydrocarbon receptor/CD36 pathway to promote hepatic steatosis in mice.
Yao L; Wang C; Zhang X; Peng L; Liu W; Zhang X; Liu Y; He J; Jiang C; Ai D; Zhu Y
Hepatology; 2016 Jul; 64(1):92-105. PubMed ID: 26928949
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone-mediated up-regulation of human CYP2A6 involves the glucocorticoid receptor and increased binding of hepatic nuclear factor 4 alpha to the proximal promoter.
Onica T; Nichols K; Larin M; Ng L; Maslen A; Dvorak Z; Pascussi JM; Vilarem MJ; Maurel P; Kirby GM
Mol Pharmacol; 2008 Feb; 73(2):451-60. PubMed ID: 17978169
[TBL] [Abstract][Full Text] [Related]
8. Activation of AMPK by berberine induces hepatic lipid accumulation by upregulation of fatty acid translocase CD36 in mice.
Choi YJ; Lee KY; Jung SH; Kim HS; Shim G; Kim MG; Oh YK; Oh SH; Jun DW; Lee BH
Toxicol Appl Pharmacol; 2017 Feb; 316():74-82. PubMed ID: 28038998
[TBL] [Abstract][Full Text] [Related]
9. Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress.
Liu J; Yang P; Zuo G; He S; Tan W; Zhang X; Su C; Zhao L; Wei L; Chen Y; Ruan X; Chen Y
Lipids Health Dis; 2018 Jul; 17(1):153. PubMed ID: 30016988
[TBL] [Abstract][Full Text] [Related]
10. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis.
Zhao L; Zhang C; Luo X; Wang P; Zhou W; Zhong S; Xie Y; Jiang Y; Yang P; Tang R; Pan Q; Hall AR; Luong TV; Fan J; Varghese Z; Moorhead JF; Pinzani M; Chen Y; Ruan XZ
J Hepatol; 2018 Sep; 69(3):705-717. PubMed ID: 29705240
[TBL] [Abstract][Full Text] [Related]
11. GR-mediated FTO transactivation induces lipid accumulation in hepatocytes via demethylation of m
Hu Y; Feng Y; Zhang L; Jia Y; Cai D; Qian SB; Du M; Zhao R
RNA Biol; 2020 Jul; 17(7):930-942. PubMed ID: 32116145
[TBL] [Abstract][Full Text] [Related]
12. [KLF9 regulates hepatic lipid metabolism via inducing CD36 expression].
Zhou SS; Zhang YL; Chang YS
Sheng Li Xue Bao; 2021 Oct; 73(5):772-780. PubMed ID: 34708234
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin 1 improves hepatic steatosis in diet-induced insulin-resistant mice and is associated with hepatic fat content in humans.
Bai J; Xia M; Xue Y; Ma F; Cui A; Sun Y; Han Y; Xu X; Zhang F; Hu Z; Liu Z; Liu Y; Cai G; Su W; Sun X; Wu H; Yan H; Chang X; Hu X; Bian H; Xia P; Gao J; Li Y; Gao X
EBioMedicine; 2020 Jul; 57():102849. PubMed ID: 32580141
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.
Koliwad SK; Kuo T; Shipp LE; Gray NE; Backhed F; So AY; Farese RV; Wang JC
J Biol Chem; 2009 Sep; 284(38):25593-601. PubMed ID: 19628874
[TBL] [Abstract][Full Text] [Related]
15. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
16. Adipocyte-derived Periostin mediates glucocorticoid-induced hepatosteatosis in mice.
Wan J; Shan Y; Song X; Chen S; Lu X; Jin J; Su Q; Liu B; Sun W; Li B
Mol Metab; 2020 Jan; 31():24-35. PubMed ID: 31918919
[TBL] [Abstract][Full Text] [Related]
17. Increased hepatic Fatty Acid uptake and esterification contribute to tetracycline-induced steatosis in mice.
Choi YJ; Lee CH; Lee KY; Jung SH; Lee BH
Toxicol Sci; 2015 Jun; 145(2):273-82. PubMed ID: 25745068
[TBL] [Abstract][Full Text] [Related]
18. Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP-β to the proximal promoter of norepinephrine transporter.
Zha Q; Wang Y; Fan Y; Zhu MY
J Neurochem; 2011 Nov; 119(3):654-63. PubMed ID: 21883217
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
Xie GL; Yan H; Lu ZF
Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-26a-CD36 signaling pathway: Pivotal role in lipid accumulation in hepatocytes induced by PM
Ding D; Ye G; Lin Y; Lu Y; Zhang H; Zhang X; Hong Z; Huang Q; Chi Y; Chen J; Dong S
Environ Pollut; 2019 May; 248():269-278. PubMed ID: 30798028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
